IRIS Institutional Research Information System - OPENBS Open Archive UniBS

CAROSI, Giampiero
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 19.844
AS - Asia 10.454
EU - Europa 8.083
SA - Sud America 2.162
AF - Africa 178
OC - Oceania 24
Continente sconosciuto - Info sul continente non disponibili 22
Totale 40.767
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 19.574
CN - Cina 3.832
SG - Singapore 3.384
UA - Ucraina 2.839
BR - Brasile 1.863
HK - Hong Kong 1.382
DE - Germania 1.325
IT - Italia 1.172
FI - Finlandia 641
VN - Vietnam 576
GB - Regno Unito 491
TR - Turchia 450
IE - Irlanda 443
RU - Federazione Russa 436
IN - India 328
FR - Francia 198
SE - Svezia 161
PL - Polonia 135
CA - Canada 130
BD - Bangladesh 110
AR - Argentina 105
MX - Messico 92
IQ - Iraq 59
ZA - Sudafrica 58
EC - Ecuador 57
BE - Belgio 51
ID - Indonesia 42
JP - Giappone 39
PK - Pakistan 36
AT - Austria 35
CO - Colombia 34
ES - Italia 33
NL - Olanda 32
VE - Venezuela 32
SA - Arabia Saudita 31
UZ - Uzbekistan 29
AE - Emirati Arabi Uniti 23
AU - Australia 22
IR - Iran 22
MA - Marocco 22
MU - Mauritius 22
EU - Europa 20
KE - Kenya 20
LT - Lituania 19
PY - Paraguay 19
CL - Cile 17
CZ - Repubblica Ceca 17
UY - Uruguay 15
EG - Egitto 14
IL - Israele 13
MY - Malesia 13
PE - Perù 13
JO - Giordania 12
AZ - Azerbaigian 11
HN - Honduras 9
DZ - Algeria 8
JM - Giamaica 8
PT - Portogallo 8
BF - Burkina Faso 7
QA - Qatar 7
KZ - Kazakistan 6
OM - Oman 6
PA - Panama 6
BO - Bolivia 5
CH - Svizzera 5
CR - Costa Rica 5
DO - Repubblica Dominicana 5
NI - Nicaragua 5
RO - Romania 5
SN - Senegal 5
TN - Tunisia 5
BG - Bulgaria 4
BH - Bahrain 4
ET - Etiopia 4
GR - Grecia 4
HU - Ungheria 4
KG - Kirghizistan 4
KR - Corea 4
LB - Libano 4
NG - Nigeria 4
NP - Nepal 4
SK - Slovacchia (Repubblica Slovacca) 4
AL - Albania 3
BY - Bielorussia 3
GE - Georgia 3
HR - Croazia 3
LA - Repubblica Popolare Democratica del Laos 3
LV - Lettonia 3
MN - Mongolia 3
PH - Filippine 3
TT - Trinidad e Tobago 3
AM - Armenia 2
BB - Barbados 2
GT - Guatemala 2
GY - Guiana 2
LK - Sri Lanka 2
NZ - Nuova Zelanda 2
PS - Palestinian Territory 2
RS - Serbia 2
SI - Slovenia 2
Totale 40.743
Salva come PNG Salva come JPEG
Città #
Woodbridge 2.189
Fairfield 2.160
Jacksonville 2.080
Singapore 1.664
Ashburn 1.391
Hong Kong 1.380
Houston 1.201
Wilmington 1.143
Ann Arbor 1.023
Cambridge 951
Chandler 944
Nanjing 839
Seattle 810
Princeton 807
Beijing 591
Dublin 440
New York 363
Istanbul 354
Nanchang 290
Los Angeles 282
The Dalles 251
Ho Chi Minh City 218
Buffalo 217
Des Moines 203
Shenyang 199
Helsinki 198
Moscow 189
Hebei 175
Changsha 174
São Paulo 171
San Diego 147
Tianjin 140
Warsaw 131
Jiaxing 130
Jinan 130
Milan 121
Dearborn 119
Munich 104
Hanoi 101
Kunming 97
Shanghai 90
Hangzhou 81
Verona 77
San Francisco 68
Redondo Beach 64
Lancaster 63
Dallas 59
Kocaeli 56
Toronto 56
Chicago 55
Rio de Janeiro 55
Zhengzhou 55
Brescia 53
Brussels 51
Lanzhou 47
Guangzhou 44
London 42
Ningbo 41
Nuremberg 41
Santa Clara 40
Mexico City 39
Boardman 38
Turku 38
Belo Horizonte 36
Tokyo 36
Brooklyn 34
Taizhou 32
Curitiba 29
Montreal 29
Washington 29
Johannesburg 28
Leawood 28
Rome 28
Tashkent 28
Campinas 27
Brasília 26
Denver 26
Norwalk 25
Porto Alegre 25
Haikou 24
Pune 24
Biên Hòa 23
Da Nang 22
Stockholm 22
Guarulhos 21
Haiphong 21
Phoenix 21
Ribeirão Preto 21
Atlanta 20
Taiyuan 20
Augusta 19
Changchun 19
Poplar 19
Quito 19
Salvador 19
Boston 18
Guayaquil 18
Orem 18
Charlotte 17
Nairobi 17
Totale 26.258
Salva come PNG Salva come JPEG
Nome #
Cos’è la Medicina Tropicale 246
Trends in methicillin-resistant Staphylococcus aureus (MRSA) bloodstream infections: effect of the MRSA "search and isolate" strategy in a hospital in Italy with hyperendemic MRSA 237
Cohort profile: Standardized management of antiretroviral therapy cohort (MASTER cohort) 207
The evolving burden of HIV infection compared with other chronic diseases in northern Italy 202
Evaluation of Liver Fibrosis: Concordance Analysis between Noninvasive Scores (APRI and FIB-4) Evolution and Predictors in a Cohort of HIV-Infected Patients without Hepatitis C and B Infection 193
Efficacy and tolerability of topical 1% cidofovir cream for the treatment of external anogenital warts in HIV-infected persons 192
Evolution of transmitted HIV-1 drug resistance in HIV-1-infected patients in Italy from 2000 to 2010. 189
Hepatitis C infection influence on immune recovery in HIV-positive patients on successful HAART: The role of genotype 3 185
Efficacy and safety of a switch to unboosted atazanavir in combination with nucleoside analogues in HIV-1-infected patients with virological suppression under antiretroviral therapy 179
Analysis of HIV-1 mutation patterns in patients failing antiretroviral therapy 168
Unboosted fosamprenavir is associated with low drug exposure in HIV-infected patients with mild-moderate liver impairment resulting from HCV-related cirrhosis 168
Malaria and anaemia in pregnant women in urban Zanzibar, Tanzania. 164
HIV-associated asymmetric lipodystrophy syndrome 164
Trigger-oriented HIV testing at Internal Medicine hospital Departments in Northern Italy: an observational study (Fo.C.S. Study) 162
Modifications of health resource-use in Italy after the introduction of highly active antiretroviral therapy (HAART) for human immunodeficiency virus (HIV) infection. Pharmaco-economic implications in a population-based setting 161
Use of efavirenz or atazanavir/ritonavir is associated with better clinical outcomes of HAART compared to other protease inhibitors: Routine evidence from the Italian MASTER Cohort 160
No evidence of relation between peripheral neuropathy and presence of hemochromatosis gene mutations in HIV-1-positive patients. 160
Genotype resistance profiles in patients failing an NNRTI-containing regimen, and modifications after stopping NNRTI therapy 157
Accidental and transfusion malaria in Italy 156
Decrease of HCVRNA after three days of daily interferon treatment is predictive of the virological response at one month 156
Key Questions in antiretroviral therapy: Italian Consensus Workshop (2005) 155
A randomized, controlled trial of triple antiviral therapy as initial treatment of chronic hepatitis C in HIV-infected patients. 155
Prediction of early and confirmed virological response by genotypic inhibitory quotients for lopinavir in patients naive for lopinavir with limited exposure to previous protease inhibitors. 155
Influence of folate serum concentration on plasma homocysteine levels in HIV-positive patients exposed to protease inhibitors undergoing HAART. 153
Pilot dose-finding trial on interferon alpha in combination with ribavirin for the treatment of chronic hepatitis C in patients not responding to interferon alone 153
HYALURONIC ACID AND LIVER STIFFNESS REDUCTION IN HIV-HEPATITIS-C (HCV) COINFECTED PATIENTS TREATED WITH A CCR5 INHIBITOR MARAVIROC (MVC) IN A RANDOMIZED CONTROLLED TRIAL (MAICOL STUDY-48-WEEK ANALYSIS) 152
Heterogeneity and penetration of HIV-1 non-subtype B viruses in an Italian province: public health implications. 152
A population-based database to study malignancies in HIV-infected patients in the Local Health Unit of Brescia (Northern Italy), period 1999-2009 150
Influence of viral chronic hepatitis co-infection on plasma drug concentrations and liver transaminase elevations upon therapy switch in HIV-positive patients. 148
Adherence and plasma drug concentrations are predictors of confirmed virologic response after 24-week salvage highly active antiretroviral therapy. 148
Hepatitis B virus and HIV coinfection in low-income countries: unmet needs. 147
Risk of chronic kidney disease among patients developing mild renal impairment during tenofovir-containing antiretroviral treatment 147
Bcl-2 expression is moderately correlated with long-term variability of CD4+ T-cell increase under successful highly active antiretroviral therapy 147
Long-Term Response in Patients Receiving Haart Including Nelfinavir: Experience from Two Italian Centers 146
Successful long-course after failure of short-course desensitization in a patient with severe hypersensitivity reaction to enfuvirtide 146
HIV susceptibility to amprenavir: phenotype-based versus rules-based interpretations 145
Incidence and risk factors for liver enzyme elevation during highly active antiretroviral therapy in HIV-HCV co-infected patients: results from the Italian EPOKA-MASTER Cohort. 143
HIV-1 genotype resistance pattern and evolution in patients failing nelfinavir containing regimens 143
Liver damage and kinetics of hepatitis C virus and human immunodeficiency virus replication during the early phases of combination antiretroviral treatment 143
Liver fibrosis progression is related to CD4 cell depletion in patients coinfected with hepatitis C virus and Human Immunodeficiency Virus. 141
Insulin resistance impairs rapid virologic response in HIV/hepatitis C virus coinfected patients on peginterferon-alfa-2a. 140
Access site-related infection in dialysis: the AStRID project: a multicenter prospective Italian study. 140
Adherence to surgical site infection guidelines in Italian cardiac surgery units. 140
Modifications in SENV DNA detection and/or SENV subtype determination over a prospective follow-up in a cohort of HIV-positive patients: is this a moving target? 139
Recent increase in enterococci, viridans streptococci, Pseudomonas spp. and multiresistant strains among haematological patients, with a negative impact on outcome. Results of a 3-year surveillance study at a single institution. 139
Access to antiretroviral therapy and disease progression in HIV+ migrants in Brescia, Italy 137
Drug resistance mutations and newly recognized treatment-related substitutions in the HIV-1 protease gene: prevalence and associations with drug exposure and real or virtual phenotypic resistance to protease inhibitors in two clinical cohorts of antiretroviral experienced patients. 136
A Multicenter, double-blind trial of a high-dose caspofungin treatment regimen versus a standard caspofungin treatment regimen for adult patients with invasive candidiasis 136
HIV-1 resistance to dideoxynucleoside reverse transcriptase inhibitors: genotypic-phenotypic correlations 136
STI epidemics in the Indian Ocean Region: can the phase be assessed? 135
Changes over time in risk factors for cardiovascular disease and use of lipid-lowering drugs in HIV-infected individuals and impact on myocardial infarction 135
High prevalence of radiological vertebral fractures in HIV-infected males 135
Caratteri generali dei protozoi patogeni per l’uomo e delle infezioni protozoarie umane 134
Interleukin-2 therapy in patients with HIV infection 134
Dermatologic conditions of the ill returned traveler: an analysis from the GeoSentinel Surveillance Network 132
Fatal disseminated toxoplasmosis during primary HIV infection. 132
Risk factors and clinical characteristics associated with hospitalization for community-acquired bacterial pneumonia in HIV-positive patients according to the presence of liver cirrhosis. 132
Long-term CD4+ T-cell count evolution after switching from regimens including HIV nucleoside reverse transcriptase inhibitors (NRTI) plus protease inhibitors to regimens containing NRTI plus non-NRTI or only NRTI 132
Major clinical outcomes in antiretroviral therapy (ART)-naive participants and in those not receiving ART at baseline in the SMART study. 131
VAGINAL COLONIZATION WITH CANDIDA SPP IN HUMAN IMMUNODEFICIENCY VIRUS-INFECTED WOMEN: A COHORT STUDY 130
Filariasis in travelers presenting to the Geosentinel Surveillance Network 130
Immune correlates of virological response in HIV-positive patients after highly active antiretroviral therapy (HAART) 130
Treatment of cytomegalovirus esophagitis in patients with acquired immune deficiency syndrome: a randomized controlled study of Foscarnet versus Ganciclovir. 129
Malaria and HIV in adults: When the parasite runs into the virus 129
A randomized controlled trial to evaluate antiretroviral salvage therapy guided by rules-based or phenotype-driven HIV-1 genotypic drug-resistance interpretation with or without concentration-controlled intervention: the Resistance and Dosage Adapted Regimens (RADAR) study. 128
HIV-related liver disease: ARV drugs, coinfection, and other risk factors. 128
Recent acquired STD and the use of HAART in the Italian Cohort of Naive for Antiretrovirals (I.Co.N.A): analysis of the incidence of newly acquired hepatitis B infection and syphilis 128
Maternal characteristics during pregnancy and risk factors for positive HIV RNA at delivery: a single-cohort observational study (Brescia, Northern Italy). 128
Characteristics of schistosomiasis in travelers reported to the GeoSentinel Surveillance Network 1997-2008 127
Baggage Malaria in Italy: Cryptic Malaria explained? 127
Safety and efficacy of raltegravir-based versus efavirenz-based combination therapy in treatment-naive patients with HIV-1 infection: a multicentre, double-blind randomised controlled trial 127
The predictive role of NLR and PLR for solid non-AIDS defining cancer incidence in HIV-infected subjects: a MASTER cohort study 127
Towards HCV extinction with modern HCV treatment? “Yes we can!” 126
Hodgkin disease developing in patients infected by human immunodeficiency virus results in clinical features and a prognosis similar to those in patients with human immunodeficiency virus-related non-Hodgkin lymphoma 126
CD4+ T cell evolution and predictors of its trend before and aftertenofovir/didanosine backbone in the presence of sustained undetectable HIV plasma viral load 126
Incidence of neutropenia and infections during combination treatment of chronic hepatitis C with pegylated interferon alfa-2a or alfa-2b plus ribavirin. 125
Impact of unreported HIV-1 reverse transcriptase mutations on phenotypic resistance to nucleoside and non-nucleoside inhibitors. 125
Real versus virtual phenotype to guide treatment in heavily pretreated patients: 48 week follow-up of the Genotipo-Fenotipo di Resistenza (GenPheRex) trial 125
Polymorphic immune restoration syndrome after effective HAART 125
Analisi estensiva di sequenza dei geni della trascrittasi inversa e della proteasi di HIV-1 in una coorte clinica di pazienti HIV positivi NAIVE per la terapia antiretrovirale. 124
Hyperbilirubinemia during atazanavir treatment in 2,404 patients in the Italian atazanavir expanded access program and MASTER Cohorts 124
Potential role of SEN virus on liver enzyme abnormalities in patients positive for hepatitis C virus with or without HIV infection. 123
Multicenter GeoSentinel analysis of rickettsial diseases in international travelers, 1996-2008 123
HIV-induced immunodeficiency and mortality from AIDS-defining and non-AIDS-defining malignancies 123
Clinical presentation and outcome of hepatocellular carcinoma in HIV infected patients. 122
Mortality for liver disease in patients with HIV infection: a cohort study 122
Risk factors for myocardial infarction in HIV positive patients 122
Therapeutic immunization with HIV-1 Tat reduces immune activation and loss of regulatory T-cells and improves immune function in subjects on HAART 122
Seasonality, annual trends, and characteristics of dengue among ill returned travelers, 1997-2006 121
Mortality from HIV and TB coinfections is higher in Eastern Europe than in Western Europe and Argentina 121
Long-term benefit of genotypic-guided therapy and prevalence of multinucleoside resistance in an Italian group of antiretroviral multiexperienced patients 121
The convenience of flow cytometry for HLA-B*5701 screening to prevent abacavir hypersensitivity reactions 121
Viral tropism by geno2pheno as a tool for predicting CD4 decrease in HIV-1-infected naive patients with high CD4 counts 121
Epidemiological features and case-management practices of imported malaria in northern Italy 120
Clinical experiences with interferon as monotherapy or in combination with ribavirin in patients co-infected with HIV and HCV 120
Italian consensus statement on paediatric HIV infection 120
Detection of drug resistance mutations at low plasma HIV-1 RNA load in a European multicentre cohort study 120
High prevalence of peripheral neuropathy in hepatitis C virus infected patients with symptomatic and asymptomatic cryoglobulinaemia 119
Supervised preventive therapy for latent tuberculosis infection in illegal immigrants in Italy 118
HIV/HTLV co-infection: frequency and epidemiological characteristics among patients admitted to an Italian hospital 118
Totale 14.241
Salva come PNG Salva come JPEG
Categoria #
all - tutte 195.122
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 195.122
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20213.176 0 0 0 0 0 609 118 590 876 339 529 115
2021/20222.828 125 538 11 185 31 170 94 190 168 433 282 601
2022/20232.769 457 24 31 232 268 820 3 272 424 25 86 127
2023/20242.154 138 68 128 149 82 370 57 53 663 23 17 406
2024/20255.883 26 18 28 594 866 515 679 186 620 362 1.212 777
2025/20266.713 1.085 1.626 850 1.711 850 591 0 0 0 0 0 0
Totale 41.175